Corona Remedies IPO Description – Incorporated in 2004, Corona Remedies is a rapidly growing India-focused pharmaceutical formulation company engaged in developing, manufacturing, and marketing branded products across women’s healthcare, cardio-diabeto, pain management, urology, and other …

Bengaluru-based fintech and loan distribution platform, Finbud Financial Services (Finance Buddha), reported strong growth in H1 FY26. Finance Buddha H1 FY26 results reported higher revenue, improved margins, and strong liquidity since listing on the NSE …

In a reaffirmation of confidence that underscores KFin Technologies’ growing stature in the fintech services space, Jefferies has maintained its Buy rating on the company, projecting as much as a 46% upside from current levels. …

Garuda Aerospace, India’s pioneering drone technology startup, has officially transitioned into a public company, marking a significant milestone in its journey from a homegrown innovation enterprise to a global drone powerhouse. The transformation, approved by …

Emmvee Photovoltaic Power has reported exceptional growth for the quarter and half year ended 30 September 2025, marking its first results since listing on the stock exchanges. Emmvee Photovoltaic Q2 FY26 results reported a stellar …

Lenskart Solutions delivered a robust financial performance for the quarter and half-year ended 30 September 2025, marking its first results disclosure post-IPO. The company’s execution and margin expansion underscore its transformation into a scalable, high-growth, …